Optogenetics is a powerful technique using photoresponsive proteins, and light-inducible dimerization (LID) systems, an optogenetic tool, allow to manipulate intracellular signaling pathways. One of the red/far-red responsive LID system, phytochrome B (PhyB)-phytochrome interacting factor (PIF), has a unique property of controlling both association and dissociation by light on the second time scale, but PhyB requires a linear tetrapyrrole chromophore such as phytochromobilin or phycocyanobilin (PCB), and such chromophores are present only in higher plants and cyanobacteria. Here, we report that we further improved our previously developed PCB synthesis system (synPCB), and successfully established a stable cell line containing a genetically encoded PhyB-PIF LID system. First, four genes responsible for PCB synthesis, namely, PcyA, HO1, Fd, and Fnr, were replaced with their counterparts derived from thermophilic cyanobacteria. Second, Fnr was truncated, followed by fusion with Fd to generate a chimeric protein, tFnr-Fd. Third, these genes were concatenated with P2A peptide cDNAs for polycistronic expression, resulting in an approximately 4-fold increase in PCB synthesis compared with the previous version. Finally, we incorporated PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors, which enabled us to induce PCB synthesis and PhyB-PIF LID system by doxycycline treatment. These tools provide a new opportunity to advance our understanding of the causal relationship between intracellular signaling and cellular functions.
Introduction
Optogenetics is an emerging technique that employs photoreceptor proteins to control protein and cellular functions by light [1] [2] [3] . Among optogenetic tools, light-induced dimerization (LID) systems allow the optical manipulation of intracellular signaling [4] [5] [6] [7] , gene expression 8 and organelle transport 9 . The Avena sativa light-oxygen-voltage (LOV) domain and Arabidopsis thaliana Cryptochrome 2 (CRY2) have been widely used as photoresponsive proteins for lightinduced protein-protein hetero-dimerization 10, 11 . This is partly because LOV and CRY2 do not require an exogenous chromophore such as flavin mononucleotide (FMN) or flavin adenine dinucleotide (FAD). Both FMN and FAD are abundant in many organisms, and therefore LOVor CRY-based LID system can be achieved merely by expressing these proteins. Meanwhile, LOV and CRY2 exert their optogenetic effects in response to blue light, making it difficult to be used together with fluorescent proteins such as CFP and GFP. In addition, blue light illumination causes phototoxicity to many live organisms.
Arabidopsis thaliana phytochrome B (PhyB), which is a red/far-red light-absorbing photoreceptor protein involved in the control of developmental responses 12,13 , has been utilized as an optogenetic tool to manipulate gene expression and intracellular signaling [14] [15] [16] . PhyB requires a chromophore such as phytochromobilin (PΦB) or phycocyanobilin (PCB) for the photoreception 17 . The chromophore covalently attaches to apo-PhyB, generating holo-PhyB 18 .
The holo-PhyB protein acts as a reversible switch in light perception; it provides photointerconversion between the red light-absorbing ground state of PhyB (Pr) and far-red light-absorbing active state of PhyB (Pfr). The PhyB (Pfr) associates with effector proteins such as phytochrome interacting factors (PIFs) 19 ( Figure 1A) . The PhyB-PIF LID system has a unique feature, showing rapid association and dissociation kinetics induced by red-and far-red-light, respectively. However, if the PhyB system is used in organisms other than photosynthetic organisms, chromophores, namely, PΦB and PCB, are required. Although researchers have added PCB purified from algae to function optogenetics with PhyB, the resulting PhyB system is technically difficult to apply in vivo, where delivery and clearance may be limitted.
To overcome this issue, we and another research group have developed a genetically encoded system for PCB synthesis in mammalian cells and fission yeasts (Figure 1 ) 20,21 . In this system, PCB can be generated by coexpression of four genes in the mitochondria-heme oxygenase 1 (HO1), PCB:ferredoxin (Fd) oxidoreductase (PcyA), ferredoxin (Fd), and Fd-NADP+ reductase (Fnr)-all of which are derived from cyanobacteria ( Figure 1A ). Further increase in PCB synthesis has been achieved by knock-out (KO) or knock-down of the biliverdin reductase A (BVRA) gene, which catalyzes the generation of bilirubin and phycocyanorubin from biliverdin and PCB, respectively 22 . The PCB synthesis system we have developed has been shown to work better than systems that externally add crude or even HPLC-purified PCBs 23 , showing a repeated cycle of association and dissociation of PhyB-PIF on the second time scale ( Figure 1B and 1C ). However, a stable cell line that can sufficiently synthesize PCB and show an optogenetic response with the PhyB-PIF system in a genetically encoded manner has not yet been established. This is because the PCB synthesis system and stable expression methods have not been fully improved and optimized.
In this study, we present a further improvement of the PCB synthesis system in mammalian cells. As a result of several modifications, the latest PCB synthesis system, synPCB2.1, realizes two-fold greater PCB synthesis compared to the previous version.
Additionally, we show that the combination of the Tol2 transposon system and doxycycline (dox)-inducible gene expression enables us to induce a high level of PCB synthesis in stable cell lines. These technical advances provide a versatile platform for the application of phytochromebased optogenetics in a broader range of living organisms.
Results and Discussion

Remodeling ferredoxin and ferredoxin-NADP+ reductase improves PCB synthesis in mammalian cells
For the synthesis of PCB in cultured mammalian cells, it is necessary to express the abovenamed four genes in the mitochondria: HO1, PcyA, Fd, and Fnr 20,21 ( Figure 1A ). In our system, the HO1 and PcyA genes were originally derived from the thermophilic cyanobacterium Thermosynechococcus elongatus BP-1, while Fd and Fnr were obtained from the freshwater cyanobacterium Synechocystis sp. PCC6803. We first replaced Fd and Fnr from Synechocystis sp. PCC6803 with those from Thermosynechococcus elongatus BP-1. Second, we deleted the CpcD-like domain at the N-terminus of Fnr (truncated Fnr, tFnr). Fnr contains a CpcD-like domain at the N-terminus responsible for Fnr binding to phycobilisomes ( Figure 2A) 24 .
We confirmed the capability of PCB synthesis by infra-red fluorescence emitted from PCB covalently bound to the PhyB-Y276H mutant ( Figure 2B ) 25 . As a control, HeLa cells expressing PhyB-Y276H-Venus were treated with mock or purified 2.5 μM PCB, and it was confirmed that clear infra-red fluorescence was only emitted from only PCB-treated cells ( Figure   2C ). PCB production was observed by the transient expression of PcyA, HO1, Fd, and Fnr, all of which were derived from thermophilic cyanobacteria, and this was further increased by substitution of Fnr for tFnr ( Figure 2C and 2D). This increase could be due to the increase in the expression level of tFnr by truncating the N-terminus. Of note, the mitochondrial targeting sequence (MTS) derived from human cytochrome C oxidase subunit VIII was fused to the Nterminus in all proteins to load these proteins into the mitochondrial matrix. The PCB fluorescence was normalized by dividing by the fluorescence intensity from PhyB-Y276H-mCherry mutants ( Figure 2D ) or PhyB-Y276H-mVenus mutants (Figure 3 )
To achieve a greater increase in PCB synthesis, we focused on enzyme clustering or colocalization, which has been shown to enhance metabolic flux through high local concentrations of enzymes and intermediate metabolites 26, 27 . We have noticed that the expression of Fd is a limiting factor for PCB synthesis. In addition, Fd is known to form a heterodimer with Fnr 28 , prompting us to generate a chimeric fusion protein to achieve higher activity of the Fd protein. Two chimeric proteins, Fd-tFnr and tFnr-Fd, were generated ( Figure   2A ), and were expressed with the PhyB-Y276H mutant, PcyA, and HO1 in HeLa cells ( Figure   2E ). Surprisingly, both chimeric proteins were competent to synthesize PCB, and tFnr-Fd showed higher PCB production than when Fd and full-length Fnr expressed separately ( Figure   2E and 2F).
synPCB: Polycistronic vectors for the synthesis of PCB
To easily introduce the genes required for PCB synthesis, we have developed a quad-cistronic vector for separate and equimolar expression of PcyA, HO1, Fd, and Fnr proteins, i.e., pPHFF ( Figure 3A ) 20 . Here, we made several modifications to Fd and Fnr, and to avoid confusion, we changed the name of the polycistronic vector for PCB synthesis from pPHFF to synPCB1.0. In synPCB1.0, the cDNAs of MTS-PcyA, MTS-HO1, MTS-Fd, and MTS-Fnr were concatenated with the cDNAs of a self-cleaving P2A peptide, enabling the polycistronic and stoichiometric expression of multiple proteins flanking the P2A peptide 29 .
First, MTS-Fd-P2A-MTS-Fnr in the original SynPCB1.0 was replaced with MTS-tFnr-Fd to generate synPCB2.0 ( Figure 3A and Figure S1 ). As in Figure 2 , the expression of synPCB2.0 in HeLa cells expressing PhyB-Y276H showed an approximately 1.5-fold increase in PCB synthesis compared to the expression of the original SynPCB1.0 ( Figure 3B and 3C ). Next, we changed the order of the gene cassettes, namely, MTS-tFnr-Fd, MTS-PcyA, and MTS-HO1, and created synPCB2.1 ( Figure 3A and Figure S1 ). The expression of synPCB2.1 further increased the activity of PCB synthesis by 3.9 times relative to the original SynPCB1.0 ( Figure   3B and 3C). This result is consistent with the fact that Fd activity is the limiting factor, and the expression level decreased as it was moved towards the end of the 2A peptide-connected construct 30 . Moreover, we generated a chimeric of HO1 and PcyA, because fusing these enzymes resulted in a huge increase in PCB production in Bacillus subtilis 31 , and included it into the polycistronic vector, yielding synPCB2.2 ( Figure 3A ). However, unexpectedly, PCB production with synPCB2.2 was lower than that with synPCB2.0 and synPCB2.1 ( Figure 3B and 3C). This may have been due to the steric hindrance between the HO1-PcyA and tFnr-Fd chimeric proteins. A similar trend was observed in HeLa cells depleted of BVRA ( Figure 3D ).
Stable and drug-inducible PCB synthesis with transposon-mediated gene transfer
Finally, we attempted to establish stable cell lines for fully genetically encoded phytochromebased optogenetics with the synPCB system. For this purpose, we used BVRA KO HeLa cells (HeLa/BVRA KO) for higher PCB production than in parental HeLa cells 20 . First, we introduced reverse tetracycline-controlled transactivator (rtTA) with lentivirus into HeLa/BVRA KO cells ( Figure 4A , left). The rtTA binds to tetracycline-responsive elements (TREs) in a doxycycline-dependent manner, and induces gene expression ( Figure 4B ).
We tested the lentivirus-and transposon-mediated gene transfer for constitutive or druginducible expression of synPCB2.0 ( Figure 4A , right). The lentivirus-mediated gene transfer failed to synthesize PCB because of an unknown gene recombination. Therefore, we employed PiggyBac and Tol2 transposon-mediated gene transfer systems 32, 33 . As a control, CAG promoter-driven transient expression of synPCB2.0 with lipofection showed reasonably high PCB production ( Figure 4C , second column). Meanwhile, the constitutive expression of synPCB2.0 through PiggyBac and Tol2 transposon showed smaller PCB fluorescence ( Figure   4C , third and sixth columns), mainly because of the difference of the copy number between transient and stable expression. For the drug-inducible system, no PCB was synthesized without doxycycline treatment ( Figure 4C , fourth and seventh columns). In both cell lines established with PiggyBac and Tol2, the cells treated with doxycycline exhibited higher PCB fluorescence than the doxycycline-untreated cells and constitutively expressing cells ( Figure 4C , fifth and eighth columns). Among them, the drug-inducible expression of synPCB2.0 introduced with Tol2 transposon showed almost the same levels of PCB production as in the transient expression of synPCB2.0 ( Figure 4D ). An increase in PCB production could be achieved by the effect of rtTA, in which the transcriptional activity of the drug-inducible system is known to be higher than that of constitutive promoters 34, 35 . Several single-cell clones were obtained from cells with the drug-inducible system established by Tol2 transposon-mediated gene transfer (HeLa/BVRA KO/rtTA/TRE-synPCB2.0), and tested in regard to the doxycycline dose-response and timecourse for PCB production; the optimal conditions were found to be 100-300 ng/mL doxycycline treatment for 20-40 hours ( Figure S2 ).
To provide proof-of-concept, we examined whether the stable cell lines suffice to show red/far-red light-dependent PhyB-PIF binding. PhyB-mCherry-HRas C-terminus (HRasCT) and PIF3-mEGFP were additionally introduced into HeLa/BVRA KO/rtTA/TRE-synPCB2.0 cells through lentivirus, followed by single-cell cloning. As we expected, the cells treated with doxycycline uniformly demonstrated clear binding of PIF3-mEGFP and PhyB-mCherry-HRasCT, which was manifested by the membrane translocation retention of PIF3-mEGFP upon red light illumination, respectively ( Figure 4E and 4F, Movie S1). This binding was restored repeatedly by far-red light illumination, indicating cytoplasmic retention of PIF3-mEGFP ( Figure 4E and 4F, Movie S1).
In this study, we succeeded in improving the PCB synthesis system and establishing stable cell clones using the improved synPCB system. Our results will make it easier to apply PhyB-and cyanobacterial phytochrome (Cph)-based optogenetics in a fully genetically encoded manner 36 . There were two key points in our improvement of PCB synthesis: the chimera of Fd and Fnr and the optimization of the order of the genes connected with the P2A sequence. The former enhances the activity of metabolic flux in PCB synthesis, while the latter optimizes the stoichiometry of these four factors. In addition, the PCB synthesis was further potentiated by introducing the doxycycline-inducible expression system. Such drug inducible systems allow not only the synthesis of PCB with appropriate timing but also a decrease in toxicity due to synPCB expression. Although the toxicity has not been observed in cultured cells (HeLa cells, mouse embryonic fibroblasts, and mouse embryonic stem cells) or fission yeast, the cytotoxicity due to synPCB expression should be minimized. These findings will open the door to the application of phytochrome-based optogenetics to higher organisms such as mice.
Methods
Plasmids
The cDNAs of PcyA and HO1 were originally derived from Thermosynechococcus elongatus BP-1 20 . The cDNAs of Fd and Fnr of Thermosynechococcus elongatus BP-1 were synthesized with codon-optimization for the human genome by FASMAC (Kanagawa, Japan). The mitochondrial targeting sequence (MTS; MSVLTPLLLRGLTGSARRLP) was derived from human cytochrome C oxidase subunit VIII. The cDNAs were subcloned into vectors through conventional ligation with Ligation high Ver.2 (Toyobo, OSAKA, Japan) or NEBuilder HiFi DNA Assembly (New England Biolabs, Ipswich, MA) according to the manufacturer's instructions. All plasmids used in this study are listed in Supplementary Table S1 . The amino acid sequences of SynPCB2 and SynPCB3 are included in Figure S1 . 
Reagents
Establishment of stable cell lines
For transposon-mediated gene transfer, cells were transfected with the PiggyBac or Tol2 transposase expression vector (mPBase or pCAGGS-T2TP; Table S1 ) and the donor vectors using 293fectin (Thermo Fisher Scientific, Waltham, MA). One day after tge transfections, cells were selected by 10 μg/mL blasticidin S (InvivoGen, San Diego, CA) or 1.0 μg/mL puromycin (InvivoGen). For lentivirus-mediated gene transfer, HEK-293T cells were cotransfected with each pCSII vector, psPax2 (a gift from Didier Trono; Addgene plasmid # 12260), and pCMV-VSV-G-RSV-Rev (a gift from Dr. Miyoshi, RIKEN BioResource Center, Ibaraki, Japan), by using polyethyleneimine "Max" MW 40,000 (Polyscience, Warrington, PA). Virus-containing media were collected 48 hours after transfection, filtered, and applied to target cells with 10 μg/mL polybrene (Nacalai Tesque). Two days after infection, the infected cells were selected with the following antibiotics: 200 μg/mL hygromycin (Wako, Osaka, Japan), 800 μg/mL G418 (InvivoGen), 10 μg/mL blasticidin S (InvivoGen), 1.0 μg/mL puromycin (InvivoGen), and 10 μg/mL zeocin (InvivoGen). Single-cell clones were isolated by the limiting dilution method. 
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Movie S1: Repeated translocation of PIF-mEGFP to the plasma membrane in HeLa cells. Figure S1 . The amino acid sequence of synPCB vectors.
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